^

Headlines

Public warned on recalled batches of anti-depressant drug

Sheila Crisostomo - The Philippine Star

MANILA, Philippines - The Food and Drug Administration (FDA) yesterday advised the public of the recall of certain batches of a drug used to treat some mental conditions.

FDA director general Kenneth Hartigan-Go said GlaxoSmithKline (GSK) Phil. Inc. initiated the recall of batch nos. 601, 602M and 603 of Paroxetine 20 mg tablet (Seroxat).

“A warning was issued by the US-FDA to GSK USA because the active pharmaceutical ingredients (API) of the manufacturer, SmithKline Beecham (Cork) Ltd. in Currabinny Carriagaline Cork in Ireland, has critical deviations which caused the Paroxetine API to be adulterated,” Go said in an advisory.

This is a violation of the current Good Manufacturing Practice (GMP), which is being enforced by the US FDA.

The US FDA provides the system that ensures proper design, monitoring and control of manufacturing processes and facilities for medicine.

Paroxetine is used to treat depression, obsessive-compulsive disorder and panic disorder with or without agoraphobia.

“Consumers are advised to buy medicine from legitimate pharmacies and drug outlets and ask for official receipt,” Go said.

vuukle comment

BEECHAM

CURRABINNY CARRIAGALINE CORK

DRUG

DRUG ADMINISTRATION

FDA

GOOD MANUFACTURING PRACTICE

KENNETH HARTIGAN-GO

LTD

PAROXETINE

SEROXAT

  • Latest
  • Trending
Latest
Latest
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with